RxDoctor Payments Data

Jeremiah Bushmaker, DPM

Foot Surgery · Galesburg, ILNPI 1114133014

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 93.3% of the total across 178 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Smith+Nephew accounts for 62.6% of it on its own, with 9 other manufacturers making up the rest. Reporting peaked in 2019 at $1,169 and has fallen 64.8% since, to $411 in 2025. Among foot surgery clinicians in IL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$4,907in general payments, 2019–2025

Across 178 payments — averaging $27.57 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Smith+Nephew$3K
  • Stryker$1K
  • Osiris Therapeutics Inc.$432
  • Integra Lifesciences Corporation$112
  • Johnson & Johnson$90
  • Organogenesis Inc.$53
  • plus $63 from 4 others

What the payments were for

  • Travel & lodging$3287%
  • Food & beverage$4,57993%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,907 in reported general payments places this provider in the 90th percentile of 51 foot surgery providers in Illinois.

See all foot surgery providers in Illinois

Medicare billing

Part B allowed, 2024
$100,433
Medicare patients
423
Services billed
1,246

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Ammonium Lactate137$2,917
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen80$799
Neomycin-Polymyxin-HydrocortNeomycin/Polymyxin B/Hydrocort12$585
Cephalexin51$419
Mupirocin32$387
Diclofenac Sodium32$330
Doxycycline Hyclate17$259
Clindamycin Hcl23$185
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav21$183
Prednisone23$103
Levofloxacin22$98
Terbinafine Hcl20$36

Paid to pharmacies, not to this prescriber.

Other foot surgery in Galesburg

See the full list for Illinois

Where these figures come from

Is this you, or does something look wrong? →